ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Class Lawsuit Alleges Cigna Discriminates by Excluding Obesity Drugs

Nation's First Lawsuit Asserting that the Affordable Care Act Forbids Exclusion of Obesity Treatment

PORTLAND, OR, June 05, 2024 /24-7PressRelease/ -- Today, Plaintiff Jamie Whittemore filed the first lawsuit in the country alleging that a health plan's exclusion of coverage for prescription medications to treat obesity violates the Affordable Care Act's anti-discrimination law. Ms. Whittemore argues that Cigna Health and Life Insurance, Inc. ("Cigna") discriminates when it excludes medically necessary prescription drugs to treat her disability which is obesity.

"Cigna's exclusion of medications to treat obesity is discrimination, plain and simple," said Eleanor Hamburger of Sirianni Youtz Spoonemore Hamburger, one of the lawyers representing Ms. Whittemore. "Other Cigna enrollees can access the prescription drug coverage that they need, while enrollees who are diagnosed with obesity have no coverage for proven, medically-effective treatment for their disability. Different treatment based on disability is illegal."

"I deserve coverage of prescription drugs to treat my medical condition, just like everyone else," said Ms. Whittemore. "Leaving my obesity untreated puts me at risk for other medical problems and negatively impacts my health and wellbeing."

"We have strong anti-discrimination laws on the books, but companies like Cigna ignore them when it comes to treatment for obesity," said Jeffrey Young of Solidarity Law, who also represents Ms. Whittemore. "Excluding effective prescription drugs for obesity makes no sense legally, medically or financially."

Ms. Whittemore works for the University of Maine System which provides her health coverage as administered by Cigna. When Ms. Whittemore's doctor prescribed Zepbound to treat her diagnosis of obesity, Cigna denied coverage. Cigna claimed that Whittemore's health plan does not cover any prescription drugs to treat obesity, even though Cigna generally covers prescription medications and considers Zepbound to be medically necessary to treat obesity.

The lawsuit is filed on behalf of a nationwide class of Cigna enrollees diagnosed with obesity by three law firms: Sirianni Youtz Spoonemore Hamburger PLLC in Seattle, Washington, Nichols Kaster, PLLP in Minneapolis, Minnesota, and Solidarity Law, PLLC in Cumberland Foreside, Maine. A copy of the Complaint can be found at www.sylaw.com/whittemorevcigna.



---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.